Is there a role for stereotactic ablation in movement disorders in the DBS era?
08:30-08:40
Host: Ilana Schlesinger, Israel
08:40-08:55
Yes: John Duda, USA
08:55-09:10
No: Abdelhamid Benazzouz, France
09:10-09:20
Discussion and rebuttals
09:20-10:10
DBS in tardive dyskinesia?
Capsule: Treatment options for tardive dyskinesias include pharmacological interventions (oral medications and Botulinum toxin injections), but the effects are limited and new pharmacological forms of tetrabenazine (eg valbenazine) are expensive. Other limitations may be the result of side effects of medications (e.g. depression or parkinsonism after tetrabenazine) and very complex form of abnormal movements (e.g. oromandibular or other segmental dystonia), difficult to treat with local injections of Botulinum toxin. Therefore, however the evidence is limited DBS may offer a good treatment option for refractory and most severe cases.
09:20-09:30
Host:
09:30-09:45
Yes: Jaroslaw Slawek, Poland
09:45-10:00
No:
10:00-10:10
Discussion and rebuttals
10:10-10:25
Coffee Break
10:25-12:05
SECTION TITLE
10:25-11:15
RLS diagnosis can be made by history alone, PSG is NOT mandatory.
10:25-10:35
Host: Lynn Rijsman, The Netherlands
10:35-10:50
Yes: Guy Leschziner, UK
10:50-11:05
PSG is mandatory: Cristian Falup-Pecurariu, Romania
11:05-11:15
Discussion and rebuttals
11:15-12:05
PET Imaging is an expensive tool with poor external validity and not relevant for future biomarker projects
11:15-11:25
Host: John Duda, USA
11:25-11:40
Yes: Jesse Cedarbaum, USA
11:40-11:55
No: Nikhil Sharma, UK
11:55-12:05
Discussion and rebuttals
12:05-12:55
Is there a role for neurosurgery in refractory Tourette syndrome